The Link between Magnesium Supplements and Statin Medication in Dyslipidemic Patients
Many investigations have discovered a connection between statins and magnesium supplements. On one hand, increasing research suggests that chronic hypomagnesemia may be an important factor in the etiology of some metabolic illnesses, including obesity and overweight, insulin resistance and type 2 di...
Main Authors: | Roxana Nartea, Brindusa Ilinca Mitoiu, Ioana Ghiorghiu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Current Issues in Molecular Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/1467-3045/45/4/205 |
Similar Items
-
Factors associated with statin-related adverse muscular events in adult dyslipidemic outpatients
by: Paula Ferreira Castro, et al.
Published: (2018-04-01) -
Association of statin use and increase in lipoprotein(a): a real-world database research
by: Tienan Feng, et al.
Published: (2023-07-01) -
Gender Difference in Statin Intervention on Blood Lipid Control among Patients with Coronary Heart Disease
by: Chun-Yen Chen, et al.
Published: (2013-06-01) -
A Scoping Review on the Reported Evidence and Gaps of the Risk of Diabetes in Dyslipidemic Patients under Statin Therapy
by: Jyotsna Needamangalam Balaji, et al.
Published: (2022-07-01) -
Adherence to Statin Therapy and Attainment of LDL Cholesterol Goal Among Patients with Type 2 Diabetes and Dyslipidemia
by: Alwhaibi M, et al.
Published: (2019-12-01)